ulipristal acetate has been researched along with Leiomyomatosis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biglia, N; D'alonzo, M; Garbagnati, M; Menato, G; Modaffari, P; Pecchio, S | 1 |
| Brun, JL; Froeliger, A; Monseau-Thiburce, AC; Rajaonarison, J; Randriamboavonjy, R; Vogler, A | 1 |
| Badiani, B; Chiumente, M; Messori, A | 1 |
| Carmona, F; Gracia, M; Martínez-Zamora, MÁ; Nonell, R; Quintas, L; Rius, M; Ros, C | 1 |
| Ciebiera, M; Jakiel, G; Męczekalski, B; Łukaszuk, K | 1 |
| Benlolo, S; Murji, A; Papillon-Smith, J | 1 |
| Biterna Tejeiro, A; Fernández de Castillo Torras, L; Pla Farnós, MJ; Ponce Sebastià, J | 1 |
| Alessandri, F; Ferrero, S; Leone Roberti Maggiore, U; Vellone, VG; Venturini, PL | 1 |
| Arriagada, P; Costa, AP; Fernandez, H; Powell, M; Schmidt, T; Thaler, C | 1 |
1 review(s) available for ulipristal acetate and Leiomyomatosis
| Article | Year |
|---|---|
Unexpected uterine leiomyosarcoma in a woman with multiple myomas treated with ulipristal acetate: case report and literature review.
Topics: Female; Humans; Leiomyomatosis; Leiomyosarcoma; Middle Aged; Norpregnadienes; Uterine Neoplasms | 2018 |
8 other study(ies) available for ulipristal acetate and Leiomyomatosis
| Article | Year |
|---|---|
Outcome of patients with uterine fibroids after 3-month ulipristal acetate therapy.
Topics: Adult; Antineoplastic Agents, Hormonal; Cohort Studies; Contraceptives, Oral, Hormonal; Drug Resistance; Female; France; Hospitals, University; Humans; Leiomyoma; Leiomyomatosis; Magnetic Resonance Imaging; Menorrhagia; Norpregnadienes; Pelvic Pain; Retrospective Studies; Slovenia; Tumor Burden; Ultrasonography; Uterine Neoplasms; Young Adult | 2018 |
Ulipristal acetate for pre-operative management of uterine fibroids: Modeling outcomes and costs.
Topics: Adult; Cohort Studies; Combined Modality Therapy; Contraceptives, Oral, Hormonal; Cost-Benefit Analysis; Female; Health Care Costs; Humans; Hysterectomy; Italy; Leiomyoma; Leiomyomatosis; Models, Economic; Norpregnadienes; Preoperative Care; Quality of Life; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Artery Embolization; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms | 2018 |
Sonographic and hysteroscopic endometrial examination in women treated with ulipristal acetate: Exploratory findings at a tertiary referral center.
Topics: Adult; Endometrium; Female; Humans; Hysteroscopy; Leiomyomatosis; Middle Aged; Norpregnadienes; Prospective Studies; Ultrasonography; Uterine Neoplasms | 2019 |
Potential synergism between ulipristal acetate and vitamin D3 in uterine fibroid pharmacotherapy - 2 case studies.
Topics: Adult; Antineoplastic Agents, Hormonal; Cholecalciferol; Drug Synergism; Drug Therapy, Combination; Female; Humans; Leiomyomatosis; Middle Aged; Norpregnadienes; Treatment Outcome; Uterine Neoplasms | 2019 |
Ulipristal Acetate for Disseminated Peritoneal Leiomyomatosis.
Topics: Contraceptive Agents, Hormonal; Female; Humans; Leiomyomatosis; Norpregnadienes; Peritoneal Neoplasms; Retreatment; Young Adult | 2019 |
Treatment with ulipristal acetate (Esmya(®)) and plasma levels of tacrolimus: a case report.
Topics: Adult; Cholangitis; Drug Interactions; Female; Humans; Hysterectomy; Immunosuppressive Agents; Leiomyomatosis; Liver Transplantation; Mycophenolic Acid; Norpregnadienes; Tacrolimus; Treatment Outcome; Uterine Neoplasms | 2016 |
Three-month treatment with ulipristal acetate prior to laparoscopic myomectomy of large uterine myomas: a retrospective study.
Topics: Adult; Blood Loss, Surgical; Databases, Factual; Female; Humans; Laparoscopy; Leiomyomatosis; Norpregnadienes; Operative Time; Retrospective Studies; Treatment Outcome; Uterine Myomectomy; Uterine Neoplasms | 2016 |
Real world data of 1473 patients treated with ulipristal acetate for uterine fibroids: Premya study results.
Topics: Abdominal Pain; Adult; Cohort Studies; Contraceptive Agents; European Union; Female; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Leiomyoma; Leiomyomatosis; Middle Aged; Norpregnadienes; Organ Sparing Treatments; Prospective Studies; Quality of Life; Severity of Illness Index; Uterine Diseases; Uterine Hemorrhage; Uterine Myomectomy; Uterine Neoplasms | 2017 |